Latest News

Governor signs bill mandating more opt-out information on step therapy programs

The bill becomes law July 1. Managed care plans and insurance companies will soon have to provide customers with more information about step therapy programs, including how to... Continue Reading

Anifrolumab Increases Odds of Earlier, Sustained Low Disease Activity vs Placebo in Lupus

Patients with systemic lupus erythematosus receiving anifrolumab are more likely to achieve earlier, more frequent and longer low disease activity, compared with those taking ... Continue Reading

Telemedicine Usage Remains High Among Rheumatologists

There was an explosion in the use of telemedicine during the COVID-19 pandemic, but usage has stabilized and varies between specialties. However, telemedicine use is still som... Continue Reading

FDA Approves Abaloparatide to Treat Men with Osteoporosis & High Risk of Fracture

This latest FDA approval was based on findings of a 12-month, safety and efficacy study of subcutaneous abaloparatide in men with osteoporosis. The multicenter, phase 3 study ... Continue Reading

UK’s Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

Dr Arturo Reyes Sandoval is the Director of the National Polytechnic Institute, one of the largest and most prestigious universities in Mexico. He specialized as a chemist, ba... Continue Reading

Trial assesses the impact of two immunomodulators in reducing CV risk among rheumatoid arthritis patients

People with rheumatoid arthritis are at increased risk of cardiovascular (CV) disease, with studies indicating an approximate 50 percent increase in risk of CV events such as ... Continue Reading

Exploring the effects of dietary fiber on gut microbiome and inflammatory diseases

In a recent study published in Medicine in Microecology, researchers reviewed how dietary fibers modulate the composition and function of gut microbiota. Diet is considered an... Continue Reading